|
Symbol
|
RMALXV | RMAQ1V | NUHRCH | RMADXV | RMAG6V | HZWEFG | KYCYDU | KYCUDU | RMAZKV | RMAUGV | OJSRCH | RMA23V | KYGDDU | KYFWDU | AAAHTQ | KYHHDU | KYDNDU | RMA7AV | AAHKTQ | OMFRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible |
|
Underlying
|
Nestlé S.A. / Novartis Sandoz Basket / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N / UBS Group AG | Julius Baer Group / Partners Group Hldg. AG / UBS Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Novartis AG / Roche PS / Swiss Life Hldg. N / UBS Group AG | Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Julius Baer Group / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Partners Group Hldg. AG / Swissquote Group Hldg. S.A. / UBS Group AG | Nestlé S.A. / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG / Zurich Insurance Group AG | Alcon / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Novartis AG / Straumann Hldg. AG / UBS Group AG | Nestlé S.A. / Roche PS / UBS Group AG | Compagnie Financière Richemont SA / Kühne & Nagel Intl. AG / Lonza Group N / UBS Group AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
22.06.2026 | 10.08.2026 | 26.08.2026 | 19.04.2027 | 24.11.2026 | 22.05.2026 | 05.06.2026 | 05.06.2026 | 08.06.2026 | 26.05.2026 | 14.06.2027 | 21.12.2026 | 29.06.2026 | 29.06.2026 | 24.06.2026 | 03.07.2026 | 12.06.2026 | 06.07.2026 | 08.07.2026 | 08.07.2026 |
| Bid | 99.90 | 100.10 | 99.52 | 98.00 | 100.00 | 102.15 | 96.95 | 96.90 | 100.00 | 99.60 | 96.54 | 98.50 | 95.45 | 95.45 | 98.70 | 96.45 | 95.65 | 98.50 | 100.16 | 100.01 |
| Ask | 101.10 | 101.30 | - | 99.20 | 101.40 | - | 97.95 | 97.90 | 101.20 | - | 97.34 | 99.70 | 96.45 | 96.45 | - | 97.45 | 96.65 | 99.70 | - | - |